Advanced non-small cell lung cancer - treatment with Pembrolizumab

被引：1
|
作者：
Silvinato, Antonio [1 ]
Floriano, Idevaldo [1 ]
Bernardo, Wanderley Marques [2 ]
机构：
[1] Assoc Med Brasileira, Sao Paulo, SP, Brazil
[2] Assoc Med Brasileira, Programa Diretrizes, Sao Paulo, SP, Brazil
来源：
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA | 2020年 / 66卷 / 03期
关键词：
D O I：
10.1590/1806-9282.66.3.256
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [41] Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab
    Hitomi Jo
    Tatsuya Yoshida
    Hidehito Horinouchi
    Shigehiro Yagishita
    Yuji Matsumoto
    Yuki Shinno
    Yusuke Okuma
    Yasushi Goto
    Noboru Yamamoto
    Kazuhisa Takahashi
    Noriko Motoi
    Yuichiro Ohe
    [J]. Cancer Immunology, Immunotherapy, 2022, 71 : 387 - 398
  • [42] Pembrolizumab plus allogeneic NK cells in advanced non-small cell lung cancer patients
    Lin, Mao
    Luo, Haihua
    Liang, Shuzhen
    Chen, Jibing
    Liu, Aihua
    Niu, Lizhi
    Jiang, Yong
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05): : 2560 - 2569
  • [43] Advances in the Treatment of Non-small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and Atezolizumab
    Leventakos, Konstantinos
    Mansfield, Aaron S.
    [J]. BIODRUGS, 2016, 30 (05) : 397 - 405
  • [44] Pembrolizumab monotherapy for advanced/recurrent non-small cell lung cancer: a Greater Manchester experience
    Tivey, A.
    Wu, K. S.
    Tay, R.
    Gomes, F.
    Taylor, P.
    Blackhall, F.
    Summers, Y.
    Califano, R.
    Cove-Smith, L.
    [J]. LUNG CANCER, 2019, 127 : S45 - S46
  • [45] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    [J]. DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
  • [46] CRIZOTINIB FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Bowles, D. W.
    Weickhardt, A. J.
    Doebele, R. C.
    Camidge, D. R.
    Jimeno, A.
    [J]. DRUGS OF TODAY, 2012, 48 (04) : 271 - 282
  • [47] IMPROVING TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Reck, M.
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4038 - 4038
  • [48] TREATMENT OF ADVANCED NON-SMALL CELL LUNG-CANCER WITH BISANTRENE
    FUKS, JZ
    VANECHO, DA
    GARBINO, C
    KASDORF, H
    AISNER, J
    [J]. CANCER TREATMENT REPORTS, 1983, 67 (06): : 597 - 598
  • [49] The safety of nivolumab for the treatment of advanced non-small cell lung cancer
    Metro, Giulio
    Ricciuti, Biagio
    Brambilla, Marta
    Baglivo, Sara
    Soli, Irene
    Minenza, Elisa
    Leonardi, Giulia Costanza
    D'arpino, Alessandro
    Colabrese, Daniela
    Tazza, Marco
    Zicari, Daniela
    Minotti, Vincenzo
    Chiari, Rita
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (01) : 101 - 109
  • [50] Immunotherapy in treatment naive advanced non-small cell lung cancer
    Ernani, Vinicius
    Ganti, Apar Kishor
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S412 - S421
12345